A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse

Biology of Blood and Marrow Transplantation

Volumn 5, Issue 1, 1999, Pages 28-35

  Üstün, Celalettin ^a   Arslan, Önder ^a   Beksaç, Meral ^a   Koç, Haluk ^a   Gürman, Günhan ^a   Özçelik, Tayfun ^b   Yilmaz, Buket ^b   Ilban, Osman ^a   Akan, Hamdi ^a   Özcan, Muhit ^a   Demirer, Taner ^a   Uysal, Akm ^a   Konuk, Nabide ^a   Arat, Mutlu ^a   Dilek, Imdat ^a   Çelebi, Harika ^a   Senol Coskun, H ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b BILKENT UNIVERSITY   (Turkey)

Author keywords

Bone marrow; Peripheral stem cell; Transplantation

Indexed keywords

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RECURRENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TURKEY;

EID: 0032616283     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.1999.v5.pm10232738     Document Type: Article

References (30)

1. Invards D, Kessinger A: Peripheral blood stem cell transplantation: historical perspective, current status, and prospect for the future. Transfus Med Rev 6:183, 1992.
2. Schmitz N, Dreger P, Suttorp M, Robwedder EB, Haferlach T, Löffer H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF). Blood 85:1666, 1995.
3. Korbling M, Przepiorka D, Hub YO, Engel H, Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85:1659, 1995.
4. Bensinger WI, Clift RA, Anasetti C, Applebaum FA, Demirer T, Rowley S, Sandmaier BM, Torok-Storb B, Starb R, Buckner D: Transplantation of allogeneic peripheral stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 14:90, 1996.
5. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Loffler H, Muller-Rucbboltz W, Schmitz N: G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft. Br J Haematol 87:609, 1994.
6. Feirara JLM, Deeg HJ, Burakof SJ: Graft-vs.-Host Disease, 2nd edition. New York, NY: Marcel Dekker, 1997.
7. Majolino I, Saglio G, Scime R, Serra A, Cavallaro AM, Fiandaca T, Vasta S, Pampinella M, Catania P, Indoniva A, Marceno R, Santora A: High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 17:555, 1996.
8. Urbano-Ispizua A, Garcia-Conde J, Brunet S, Hernandez F, Sanz G, Alegre A, Petit J, Bargay J, Vivancos P, Solano C, Ojeda E, Domingo A, Rozman C, for the Spanish Group of alloPBPCT: High incidence of chronic graft versus host disease (GVHD) after allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT) from matched related donors. Blood 88 (Suppl 1):2455a, 1996.
9. Körbling M, Mirza M, Thall P, Przepiorka D, Anderlini P, Hub Y, Fischer H, Fabmy H, Champlin R: 100 HLA-identical allogeneic blood stem cell transplantations: the MD Anderson Cancer Center experience. Bone Marrow Transplant 19 (Suppl 1):S72, 1997.
10. Russell JA, Desai S, Herbur B, Brown C, Luider J, Ruether JD, Stewart D, Chaudbry A, Booth K, Jorgeson K, Coppes MJ, Turner AR, Larratt L, Poon MC, Klassen J: Partially mismatched blood cell transplantation for high-risk hematologic malignancy. Bone Marrow Transplant 19:861, 1997.
11. Miflin G, Russell NH, Hutchinson RM, Morgan G, Potter M, Pagliuca A, Marsh J, Bell A, Milligan D, Lumley M, Cook G, Franklin I: Allogeneic peripheral blood stem cell transplantation for haematological malignancies - an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant 19:9, 1997.
12. Özbek U, Vural B, Kalayoǧlu S, Soysal T, Bilgen H, Yavuz S, Anak S, Sargin D, Gedikoglu G, Ferbanoglu B, Akoǧlu T, Tangün Y, Özçelik T: Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation. Turk Pediatr 39:303, 1997.
13. Russell NH, Hunter A, Rogers S, Hanley J, Anderson D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341:1482, 1993.
14. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner D: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematological malignancies: a retrospective comparison with marrow transplantation. Blood 88:2794, 1996.
15. Demirer T, Bensinger WI: Optimization of peripheral blood stem cell collection. Curr Opin Hematol 2:219, 1995.
16. Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algara S, Bierman PJ, Vose JM, Reed EC, Gross TG, Kollath J, Nasrati K, Jackson JD, Annitage JO, Kessinger A: Hematopoietic recovery after allogeneic blood stem-cell transplantation in patients with hematologic malignancies. J Clin Oncol 15:1608, 1997.
17. Koç H, Gürman G, Arslan Özcan M, Dilek Y, İlban O, Konuk N, Beksaç M, Uysal A: Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs. host disease? J Chemother 9:371, 1997.
18. Koç H, Gürman G, Arslan Özcan M, Akan H, İlban O, Konuk N, Beksaç M, Uysal A: Is there an increased risk of graft versus host disease after allogeneic peripheral blood stem cell transplantation? Blood 86:2362, 1996.
19. Niederwieser D, Pepe M, Storb R, Witherspoon R, Longton G, Sulvian K: Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplant 4:151, 1989.
20. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringden O: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459, 1990.
21. Storb R, Pretince RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Applebaum FA, Sanders JE, Stewart PS, Thomas ED: Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98:461, 1983.
22. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR: Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90:4705, 1997.
23. Leopardi G, Bandini G, Lemoli RM, Campanini E, Rondelli D, Stanzani M, Bonini A, Tura S: Is GVHD following allogeneic peripheral blood stem cell transplant (PBSCT) different from that of marrow transplant? Bone Marrow Transplant 21 (Suppl 1):122, 1998.
24. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ: Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19:161, 1997.
25. Korngold R, Sprent J: Variable capacity of L3T41 T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 165:1522, 1987.
26. Korngold R, Sprent J: Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev 71:5, 1983.
27. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R: Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300:1068, 1979.
28. Weiden P, Sullivan KM, Flournoy N, Storb R, Thomas ED: Antileukemic effect of chronic-graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529, 1981.
29. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B: Graft-versus-host leukemia reactions after bone marrow transplantation. Blood 75:555, 1990.
30. Korbling M, Mirza N, Thall P, Przepiorka D, Anderlini P, Hub Y, Fisher H, Fabmi H, Champlin R: 100 HLA-identical allogeneic blood stem cell transplantation: the M.D. Anderson cancer experience. Bone Marrow Transplant 19 (Suppl 1):S72, 1997.